Concepedia

Samy Metyas

SM

Statistics

Publications

9

Citations

911

H-Index

9

Active since

2006

Affiliations

University of Southern California(Current)

Samy Metyas is an author at University of Southern California specializing in medicine, rheumatology, and pharmacotherapy.

Publications per year

2006–2019

9

Publications

9

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12

Cryoneurolysis to treat the pain and symptoms of knee osteoarthritis: a multicenter, randomized, double-blind, sham-controlled trial

Richard Radnovich, David F. Scott, A.T. Patel et al. · Osteoarthritis and Cartilage · 2017 · 144 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Rituximab treatment for resistant antiphospholipid syndrome.

Elyse Rubenstein, Daniel G. Arkfeld, Samy Metyas et al. · PubMed · 2006 · 120 citations

Medicine, Hematology, Pharmacotherapy +14

Combination Therapy of Apremilast and Biologic Agent as a Safe Option of Psoriatic Arthritis and Psoriasis

Samy Metyas, Christopher Tomassian, Ramy Messiah et al. · Current Rheumatology Reviews · 2018 · 35 citations

Medicine, Pharmacology, Pharmacotherapy +17

Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis

Samy Metyas, Rafik Tadros, Daniel G. Arkfeld · Rheumatology International · 2008 · 34 citations

Life Sciences, Immunology, Pathology +14

1–5 of 9